Quest Diagnostics
485 hedge funds and large institutions have $8.81B invested in Quest Diagnostics in 2014 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 158 increasing their positions, 199 reducing their positions, and 45 closing their positions.
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
1% more capital invested
Capital invested by funds: $8.72B → $8.81B (+$84.4M)
1.01% less ownership
Funds ownership: 102.83% → 101.82% (-1%)
2% less funds holding
Funds holding: 496 → 485 (-11)
20% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 45
21% less repeat investments, than reductions
Existing positions increased: 158 | Existing positions reduced: 199
41% less call options, than puts
Call options by funds: $122M | Put options by funds: $206M
Top Buyers
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$119M |
| 2 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$49.1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$47.9M |
| 4 |
T
TOBAM
Paris,
France
|
+$40.7M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$30.6M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAS
526
Partnervest Advisory Services
Santa Barbara,
California
| – | -$66K | -1,119 | Closed |
|
527
Parallax Volatility Advisers
San Francisco,
California
| – | -$64K | -1,038 | Closed |
|
|
BRWA
528
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$27.9K | -476 | Closed |
|
|
BBHC
529
Brown Brothers Harriman & Co
New York
| – | -$16K | -276 | Closed |
|
|
BCAM
530
Boston Common Asset Management
Boston,
Massachusetts
| – | -$15K | -250 | Closed |
|
|
DM
531
Delphi Management
Brookline,
Massachusetts
| – | -$13K | -220 | Closed |
|
DGX Hedge Fund Activity: Q3 2014 in Review
485 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2014, worth a combined $8.81B — up 0.97% from $8.72B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of DGX and 36 opened new positions — a net loss of 9 holders — while 199 trimmed existing stakes and 158 added.
The largest buyer was Fidelity International, opening a new position worth an estimated $119M. The largest seller was Norges Bank, cutting an estimated $74.9M.
- 485 institutional investors held Quest Diagnostics (DGX) as of Q3 2014, down from 496 in Q2 2014.
- Funds reported $8.81B of Quest Diagnostics stock for Q3 2014, up 0.97% quarter-over-quarter.
- 36 funds opened new Quest Diagnostics positions in Q3 2014 and 45 closed out, a net change of -9 holders.
- The largest Quest Diagnostics buyer in Q3 2014 was Fidelity International, an estimated $119M added.
- The largest Quest Diagnostics seller in Q3 2014 was Norges Bank, an estimated $74.9M sold.
Based on aggregated 13F filings for Q3 2014.